Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J M van Beveren

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Tijdschrift Voor Psychiatrie|October 28, 2025
[The history of psychiatric diagnostic concepts]N J M van Beveren, N Veen, T K Birkenhager
Tijdschrift Voor Psychiatrie|January 17, 2007
[Gene-expression profiling in schizophrenia: an overview]J Verveer, K Huizer, D Fekkes, et al.
Tijdschrift Voor Psychiatrie|April 1, 2025
[External referrals within the Wvggz at a mental health institution in the Rijnmond region]Y Fransen, M A V van Verschuer, N J M van Beveren
Psychological Medicine|August 24, 2019
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysisN Çakici, N J M van Beveren, G Judge-Hundal, et al.
Journal of Psychopharmacology (Oxford, England)|June 20, 2008
Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophreniaR J Hempel, J H M Tulen, N J M van Beveren, et al.
Psychological Medicine|July 19, 2012
Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controlsR M C Klaassen, M Heins, L B Luteijn, et al.
Annual Review of Clinical Psychology|July 12, 2024
Immune Dysfunction in Schizophrenia Spectrum DisordersS S Gangadin, A D Enthoven, N J M van Beveren, et al.
Translational Psychiatry|August 27, 2014
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaN J M van Beveren, E Schwarz, R Noll, et al.
Psychological Medicine|September 9, 2011
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblingsJ H Meijer, N Dekker, M W Koeter, et al.
Molecular Psychiatry|April 13, 2011
Identification of a biological signature for schizophrenia in serumE Schwarz, P C Guest, H Rahmoune, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Tijdschrift Voor Psychiatrie|October 28, 2025
[The history of psychiatric diagnostic concepts]N J M van Beveren, N Veen, T K Birkenhager
Tijdschrift Voor Psychiatrie|January 17, 2007
[Gene-expression profiling in schizophrenia: an overview]J Verveer, K Huizer, D Fekkes, et al.
Tijdschrift Voor Psychiatrie|April 1, 2025
[External referrals within the Wvggz at a mental health institution in the Rijnmond region]Y Fransen, M A V van Verschuer, N J M van Beveren
Psychological Medicine|August 24, 2019
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysisN Çakici, N J M van Beveren, G Judge-Hundal, et al.
Journal of Psychopharmacology (Oxford, England)|June 20, 2008
Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophreniaR J Hempel, J H M Tulen, N J M van Beveren, et al.
Psychological Medicine|July 19, 2012
Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controlsR M C Klaassen, M Heins, L B Luteijn, et al.
Annual Review of Clinical Psychology|July 12, 2024
Immune Dysfunction in Schizophrenia Spectrum DisordersS S Gangadin, A D Enthoven, N J M van Beveren, et al.
Translational Psychiatry|August 27, 2014
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaN J M van Beveren, E Schwarz, R Noll, et al.
Psychological Medicine|September 9, 2011
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblingsJ H Meijer, N Dekker, M W Koeter, et al.
Molecular Psychiatry|April 13, 2011
Identification of a biological signature for schizophrenia in serumE Schwarz, P C Guest, H Rahmoune, et al.
Pageof 2